Erica holds a M.S. degree in Biochemistry and Molecular Biology from UC Riverside and a Pharm.D. from UC San Diego. She first joined Roche Clinical Pharmacology in 2008 as a Post-doctoral Fellow. Erica has worked on a number of biologic (antibodies, proteins) and small molecule projects in oncology, inflammation and virology. Her experience in drug development spans early phase: bridging from pre-clinical to clinical, phase I/II study design, dose finding activities, modeling and simulation to late phase and NDA filing. She recently re-joined Roche/Genentech after working for a small company in NYC that specialized in transdermal drug development.